~~<i id='4120DDE453'><strike id='4120DDE453'><tt id='4120DDE453'><pre id='4120DDE453'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：focus 2025-09-02 08:18:54 - browse：72485

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Fentanyl is making it harder to start addiction treatment

focus

hotspot

entertainment

focus

hotspot

AdobeTheFoodandDrugAdministrationhasclearedOtsukaPharmaceutical’sdigitaltreatmentformajordepressived

WSS

Multiple sclerosis has subtypes with different best treatments: study

Making the case for fair compensation in clinical trials

Multiple sclerosis has subtypes with different best treatments: study

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Scientists uncover potential path to treating deadly childhood tumor

Medicare Advantage 2025 payments will dip, Biden administration says

entertainment

entertainment

focus

Medicare details structure of new drug price negotiation program

Oral obesity drug from Viking Therapeutics hits key early target

Moonlake's readout produced a cash windfall. Risks remain

H5N1 virus can be tracked in retail milk, scientists say

The high cost of giving birth even with insurance

Overprescribed: High cost isn't America's only drug problem

Affirmative action in medical school literally saved lives

Drug companies' payments and gifts affect physicians' prescribing

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Reports of telehealth's death have been greatly exaggerated

hotspot

Hundreds died while taking an arthritis drug, but nobody alerted patients

Digital health: a case of mistaken identity

Medicare Advantage 2025 payments will dip, Biden administration says

For longer

Cue Health, Covid

Bird flu surveillance in wastewater gets boost from consortium

entertainment

focus

focus

hotspot